Evidence map›Paper›PMID 21368182›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Rational development of a strategy for modifying the aggregatibility of proteins.

Zhongping Tan, Shiying Shang, Samuel J Danishefsky

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. At last: erythropoietin as a single glycoform.Angewandte Chemie (International ed. in English) · 2012
    Article
  16. Article
  17. Article
  18. Article
  19. An advance in proline ligation.Journal of the American Chemical Society · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zhongping TanBio-Organic Chemistry Laboratory, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Shiying Shang
Samuel J Danishefsky
Memorial Sloan Kettering Cancer Center · USColumbia University · US

Funding

Synthesis of Antitumor Natural ProductsR37CA028824 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI DANISHEFSKY, SAMUEL J · 2002 to 2011
$6.9M
THE SYNTHESIS OF ANTITUMOR NATURAL PRODUCTSR01CA028824 · NCI · YALE UNIVERSITY · PI CHIOSIS, GABRIELA · 1985 to 2016
$2.7M
NCI NIH HHS CA28824NCI NIH HHS R01 CA028824NCI NIH HHS R37 CA028824
6 · The paper itself

Abstract

The conversion of peptide and proteins from their soluble state into well-organized aggregates, together with the accompanied oxidation of methionine residue, presents a significant challenge to human health, to the manufacture of protein therapeutics, and to the synthesis of proteins and glycoproteins. Despite their fundamental importance, little is known about the molecular basis of these two side reactions and their control. Here, using chemical peptide synthesis, we further confirmed the importance of the balance between hydrophobic interactions and electrostatic repulsive forces in inducing and inhibiting aggregation and methionine oxidation. Most importantly, through extending the established principle, we are able to effectively stabilize the problematic peptide fragment through the attachment of cleavable arginine tags. Future applications of our approach are expected to facilitate the synthesis and study of difficult peptides, proteins, and glycoproteins and will provide more opportunities for the optimization of protein biopharmaceuticals and for the development of cell-permeable biomolecules.

Indexed as

Amino Acid SequenceBiochemistryChromatography, LiquidErythropoietinHumansMass SpectrometryMethionineMolecular Sequence DataOxidation-ReductionPeptidesProteinsProtein Structure, QuaternaryErythropoietinMethioninePeptidesProteins

Identifiers

PMID21368182
PMCPMC3060265
OpenAlexW1978639788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.